Efficacy and Safety of 0.5 mg Ranibizumab Administered as Intravitreal Injections PRN Compared with Intravitreal Implant Containing 0.7 mg Dexamethasone in Patients with Branch Retinal Vein Occlusion Over 6 Months: The COMRADE-B Study

LO Hattenbach; H Hoerauf; N Feltgen; G Lang; S Taylor; S Schmitz-Valckenberg; A Wolf; T Knorr

Back

Journal article

Efficacy and Safety of 0.5 mg Ranibizumab Administered as Intravitreal Injections PRN Compared with Intravitreal Implant Containing 0.7 mg Dexamethasone in Patients with Branch Retinal Vein Occlusion Over 6 Months: The COMRADE-B Study

LO Hattenbach, H Hoerauf, N Feltgen, G Lang, S Taylor, S Schmitz-Valckenberg, A Wolf and T Knorr

OPHTHALMOLOGICA, Vol.232, pp.90-90

01/01/2014

Abstract

Science & Technology

Life Sciences & Biomedicine

Ophthalmology

Retinal Vein Occlusion

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345450600235&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202View

Author

Metrics

27 Record Views

Details

Title: Efficacy and Safety of 0.5 mg Ranibizumab Administered as Intravitreal Injections PRN Compared with Intravitreal Implant Containing 0.7 mg Dexamethasone in Patients with Branch Retinal Vein Occlusion Over 6 Months: The COMRADE-B Study
Creators: LO Hattenbach
H Hoerauf
N Feltgen
G Lang
S Taylor
S Schmitz-Valckenberg
A Wolf
T Knorr
Publication Details: OPHTHALMOLOGICA, Vol.232, pp.90-90
Publisher: KARGER
Date published: 01/01/2014
Date submitted: 17/05/2017
Identifiers: 99516404102346
Academic Unit: University of Surrey
Resource Type: Journal article

Efficacy and Safety of 0.5 mg Ranibizumab Administered as Intravitreal Injections PRN Compared with Intravitreal Implant Containing 0.7 mg Dexamethasone in Patients with Branch Retinal Vein Occlusion Over 6 Months: The COMRADE-B Study

Abstract

Files and links (1)

Metrics

Details

Usage Policy